Loading...
XNAS
SBRA
Market cap4.30bUSD
May 20, Last price  
18.07USD
1D
-0.17%
1Q
9.18%
Jan 2017
-26.00%
IPO
9.52%
Name

Sabra Health Care REIT Inc

Chart & Performance

D1W1MN
P/E
33.93
P/S
6.11
EPS
0.53
Div Yield, %
4.98%
Shrs. gr., 5y
4.64%
Rev. gr., 5y
1.22%
Revenues
703m
+8.61%
8,800,00084,225,000103,170,000134,780,000183,518,000238,864,000260,526,000405,647,000623,409,000661,736,000598,569,000569,545,000624,811,000647,514,000703,235,000
Net income
127m
+821.14%
7,378,00012,842,00019,513,00033,715,00046,952,00079,413,00070,276,000158,383,000279,082,00068,996,000138,417,000-113,256,000-77,605,00013,756,000126,712,000
CFO
311m
+3.32%
6,600,00044,705,00056,252,00062,099,00085,337,000121,101,000176,739,000133,486,000358,543,000372,475,000354,852,000356,390,000315,733,000300,571,000310,541,000
Dividend
Aug 19, 20240.3 USD/sh
Earnings
Aug 05, 2025

Profile

As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (“Senior Housing - Leased”), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing - Managed”), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.
URL
https://sabrahealth.com/
IPO date
Nov 06, 2010
Employees
42
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
703,235
8.61%
647,514
3.63%
624,811
9.70%
Cost of revenue
277,155
425,804
202,187
Unusual Expense (Income)
NOPBT
426,080
221,710
422,624
NOPBT Margin
60.59%
34.24%
67.64%
Operating Taxes
1,005
2,002
1,242
Tax Rate
0.24%
0.90%
0.29%
NOPAT
425,075
219,708
421,382
Net income
126,712
821.14%
13,756
-117.73%
(77,605)
-31.48%
Dividends
(280,150)
(277,447)
(277,157)
Dividend yield
6.85%
8.35%
9.65%
Proceeds from repurchase of equity
86,121
(2,682)
(9,620)
BB yield
-2.11%
0.08%
0.34%
Debt
Debt current
1,762,872
96,462
196,982
Long-term debt
53,694
2,384,738
2,549,018
Deferred revenue
2,691,277
Other long-term liabilities
772,672
(2,691,277)
Net debt
1,573,179
2,245,223
2,561,730
Cash flow
Cash from operating activities
310,541
300,571
315,733
CAPEX
Cash from investing activities
(109,001)
103,130
(216,248)
Cash from financing activities
(181,561)
(410,300)
(161,707)
FCF
(57,552)
5,761,235
2,187,646
Balance
Cash
60,468
41,285
49,308
Long term investments
182,919
194,692
134,962
Excess cash
208,225
203,601
153,029
Stockholders' equity
23,316
(1,692,221)
1,064,514
Invested Capital
5,280,363
6,943,423
5,607,122
ROIC
6.95%
3.50%
6.49%
ROCE
8.03%
4.22%
7.28%
EV
Common stock shares outstanding
236,046
232,793
230,948
Price
17.32
21.37%
14.27
14.80%
12.43
-8.20%
Market cap
4,088,314
23.07%
3,321,953
15.72%
2,870,682
-3.22%
EV
5,661,493
5,567,176
7,927,498
EBITDA
595,703
404,797
610,406
EV/EBITDA
9.50
13.75
12.99
Interest
115,272
112,964
105,471
Interest/NOPBT
27.05%
50.95%
24.96%